| 000 | 01591 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516124207.0 | ||
| 264 | 0 | _c20130819 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1432-0428 | ||
| 024 | 7 |
_a10.1007/s00125-012-2794-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBonnefond, A | |
| 245 | 0 | 0 |
_aReassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes. _h[electronic resource] |
| 260 |
_bDiabetologia _cMar 2013 |
||
| 300 |
_a492-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenetic Predisposition to Disease _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 | _asrc-Family Kinases |
| 700 | 1 | _aYengo, L | |
| 700 | 1 | _aPhilippe, J | |
| 700 | 1 | _aDechaume, A | |
| 700 | 1 | _aEzzidi, I | |
| 700 | 1 | _aVaillant, E | |
| 700 | 1 | _aGjesing, A P | |
| 700 | 1 | _aAndersson, E A | |
| 700 | 1 | _aCzernichow, S | |
| 700 | 1 | _aHercberg, S | |
| 700 | 1 | _aHadjadj, S | |
| 700 | 1 | _aCharpentier, G | |
| 700 | 1 | _aLantieri, O | |
| 700 | 1 | _aBalkau, B | |
| 700 | 1 | _aMarre, M | |
| 700 | 1 | _aPedersen, O | |
| 700 | 1 | _aHansen, T | |
| 700 | 1 | _aFroguel, P | |
| 700 | 1 | _aVaxillaire, M | |
| 773 | 0 |
_tDiabetologia _gvol. 56 _gno. 3 _gp. 492-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-012-2794-8 _zAvailable from publisher's website |
| 999 |
_c22331719 _d22331719 |
||